Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection.
Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection.
复制标题
DOI:
10.1111/j.1525-139x.2011.00869.x
复制
发表时间:
2011-03
影响因子:
1.6
通讯作者:
Allon M
中科院分区:
文献类型:
--
作者:
Sychev D;Maya ID;Allon M
Dialysis catheter-related bacteremia (CRB) can frequently be treated with systemic antibiotics, in conjunction with an antibiotic lock, in an attempt to salvage the catheter. It is unknown whether CRB associated with an exit site infection can be treated with such an approach. We retrospectively queried a prospective, computerized vascular access database, and identified 1436 episodes of CRB, of which 64 cases had a concurrent exit site. The frequency of concurrent exit site infection was 9.6% with Staphylococcus epidermidis, 6.1% with Staphylococcus aureus, and only 0.7% with Gram negative CRB (p<0.001 for Staphylococcus vs Gram negative rods). Five serious complications (4 major sepsis, 1 endocarditis) occurred in 24 patients with Staphylococcus aureus infection, but none in 32 episodes of Staphylococcus epidermidis infection. Catheter survival was significantly shorter in patients with Staphylococcus aureus infections. The median catheter survival (without infection or dysfunction) was 14 days with Staphylococcus aureus vs 30 days with Staphylococcus epidermidis infection. In conclusion, concurrent exit site infection is seen most commonly in association with Staphylococcal CRB. When the infecting organism is Staphylococcus epidermidis, attempted salvage with systemic antibiotics and an antibiotic lock is reasonable. However, prompt catheter removal is indicated when the pathogen is Staphylococcus aureus.